Cargando…

Gut-brain axis in the neurological comorbidity of COVID-19

Detalles Bibliográficos
Autores principales:	Chen, Jiezhong, Vitetta, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195160/ https://www.ncbi.nlm.nih.gov/pubmed/34169281 http://dx.doi.org/10.1093/braincomms/fcab118

Ejemplares similares

Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2022)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Gut Brain axis: The gut microbiome in peri-operative medicine
por: Khan, Tazeen, et al.
Publicado: (2023)

The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
por: Chen, Jiezhong, et al.
Publicado: (2021)

Gut microbial signature and gut-lung axis: A possible role in the therapy of COVID-19
por: Mahmoodpoor, Ata, et al.
Publicado: (2022)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

The gut microbiota–brain axis in neurological disorder
por: Ullah, Hanif, et al.
Publicado: (2023)

The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems
por: Kountouras, Jannis, et al.
Publicado: (2015)

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?
por: Assante, Gabriella, et al.
Publicado: (2021)

Neurology during the pandemic. Is COVID-19 changing the organisation of neurology departments?()
por: Hernández Ramos, F.J., et al.
Publicado: (2020)

The role of gut-brain axis in SARA-CoV-2 neuroinvasion: Culprit or innocent bystander?
por: Shi, Yan, et al.
Publicado: (2021)

COVID-19 in patients with neurological disorders
por: Onteddu, Sanjeeva Reddy, et al.
Publicado: (2020)

Potential neurological symptoms of COVID-19
por: Wang, Hai-Yang, et al.
Publicado: (2020)

Neurological involvement associated with COVID-19 infection in children
por: Chen, Tai-Heng
Publicado: (2020)

COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?
por: Zhang, Ting, et al.
Publicado: (2020)

Role of vitamin D deficiency and comorbidities in COVID-19
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

The gut-immune-brain axis in neurodevelopment and neurological disorders
por: Park, John Chulhoon, et al.
Publicado: (2022)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
por: Chen, Jiezhong, et al.
Publicado: (2019)

Neurology Exams during the COVID-19 Pandemic
por: Aghoram, Rajeswari, et al.
Publicado: (2021)

Neurological infections during the COVID-19 epidemic()
por: López-Blanco, R., et al.
Publicado: (2020)

Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
por: Oroojzadeh, Parvin, et al.
Publicado: (2022)

Neurological Manifestations of COVID-19 - Continually Evolving and Perplexing
por: Ish, Pranav, et al.
Publicado: (2020)

Neurological Adverse Events Associated with COVID-19 Vaccination
por: Jadali, Zohreh
Publicado: (2023)

Myelitis with Myositis - An Unusual Neurological Complication of COVID-19
por: Pereira, Amanda L., et al.
Publicado: (2022)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Clinical and imaging features of adult COVID-19 patients with or without comorbidities
por: Xing, Li-Hong, et al.
Publicado: (2022)

Psychiatric comorbidities in chronic orofacial pain during COVID-19 pandemic
por: Maeda, Chizuko, et al.
Publicado: (2023)

The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
por: Naufel, Maria Fernanda, et al.
Publicado: (2023)

Role of hemagglutinin esterase protein in neurological manifestation of COVID-19
por: Zandi, Milad, et al.
Publicado: (2021)

Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China
por: Ding, Hong, et al.
Publicado: (2020)

Severe neurological complications in critically ill COVID-19 patients
por: Notz, Quirin, et al.
Publicado: (2020)

Neurological manifestations in 404 COVID-19 patients in Washington State
por: Agarwal, Pinky, et al.
Publicado: (2020)

Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms
por: Neumann, Bernhard, et al.
Publicado: (2020)

Neurological Involvement of COVID-19 Patients: Making the Most of MRI
por: Purcell, Yvonne, et al.
Publicado: (2020)

COVID-19: Thinking about further mental and neurological disorders
por: Monteiro-Junior, Renato Sobral
Publicado: (2020)

Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022)

Neurological complications in COVID-19 – a new diagnostic challenge
por: Vacaras, Vitalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2hmihsaa99lrmqnnu58mql6irm